Literature DB >> 28004012

Newcastle disease in Nigeria: epizootiology and current knowledge of circulating genotypes.

Ismaila Shittu1, Tony M Joannis2, Georgina N Odaibo3, Olufemi D Olaleye3.   

Abstract

Over the years, Newcastle disease (ND) has defied all available control measures. The disease has remained at the forefront of infectious diseases afflicting poultry production after avian influenza. Despite the continuous global use of million doses of ND vaccine annually, the causative pathogen, avian paramyxovirus type 1 also known as Newcastle disease virus (NDV) has continued to evolve causing, even more, a threat not only to the unvaccinated but the vaccinated flocks inclusive. The disease has been well studied in the developed countries where the virus is found in circulation. However, limited information exists on the epizootiology and circulating genotypes of the virus in developing countries where the majority of the flocks are raised on the extensive management system. Identification of virulent NDV in apparently healthy free-range ducks in this system calls for concern and pragmatic approach to investigate factor(s) that favour the virus inhabiting the ducks without clinical manifestation of the disease. Recently, novel genotypes (XIV, XVII, and XVIII) with peculiarity to West and Central African countries have been discovered and due to lack or poor surveillance system possibility of hitherto unreported genotypes are likely. This review elucidates and discusses available literature on the diversity of the circulating NDV genotypes across the West Africa countries and the epizootiology (molecular) of the disease in Nigeria with the view of identifying gaps in knowledge that can assist in the development of effective vaccines and control strategies to combat the peril of the disease.

Entities:  

Keywords:  Epizootiology; Genotypes; Newcastle disease; Nigeria; West Africa

Year:  2016        PMID: 28004012      PMCID: PMC5142595          DOI: 10.1007/s13337-016-0344-6

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  64 in total

1.  Evolutionary dynamics of multiple sublineages of H5N1 influenza viruses in Nigeria from 2006 to 2008.

Authors:  Alice Fusaro; Martha I Nelson; Tony Joannis; Luigi Bertolotti; Isabella Monne; Annalisa Salviato; Olufemi Olaleye; Ismaila Shittu; Lanre Sulaiman; Lami H Lombin; Ilaria Capua; Edward C Holmes; Giovanni Cattoli
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

2.  Newcastle disease outbreaks in the Sudan from 2003 to 2006 were caused by viruses of genotype 5d.

Authors:  Wegdan Hassan; Sobhi Ahmed Mohamed Khair; Bontsi Mochotlhoane; Celia Abolnik
Journal:  Virus Genes       Date:  2009-11-12       Impact factor: 2.332

3.  Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae.

Authors:  O de Leeuw; B Peeters
Journal:  J Gen Virol       Date:  1999-01       Impact factor: 3.891

4.  Molecular and phylogenetic characterization based on the complete genome of a virulent pathotype of Newcastle disease virus isolated in the 1970s in Brazil.

Authors:  Camila C Fernandes; Alessandro M Varani; Eliana G M Lemos; Vitor Fernandes O de Miranda; Ketherson R Silva; Filipe S Fernando; Maria F S Montassier; Helio J Montassier
Journal:  Infect Genet Evol       Date:  2014-05-24       Impact factor: 3.342

5.  Seroprevalence of avian influenza virus, infectious bronchitis virus, reovirus, avian pneumovirus, infectious laryngotracheitis virus, and avian leukosis virus in Nigerian poultry.

Authors:  A A Owoade; M F Ducatez; C P Muller
Journal:  Avian Dis       Date:  2006-06       Impact factor: 1.577

6.  Emergence of a new genetic lineage of Newcastle disease virus in West and Central Africa--implications for diagnosis and control.

Authors:  G Cattoli; A Fusaro; I Monne; S Molia; A Le Menach; B Maregeya; A Nchare; I Bangana; A Garba Maina; J-N N'Goran Koffi; H Thiam; O E M A Bezeid; A Salviato; R Nisi; C Terregino; I Capua
Journal:  Vet Microbiol       Date:  2009-10-31       Impact factor: 3.293

7.  Isolation and characterisation of Newcastle disease virus strain in a feral dove (Stigmatopelia senegalensis) in Nigeria.

Authors:  C K Ojeh; H O Okoro
Journal:  Trop Anim Health Prod       Date:  1992-11       Impact factor: 1.559

8.  Isolation and molecular characterization of Newcastle disease virus genotypes II and VIId in Egypt between 2011 and 2012.

Authors:  M M Radwan; S F Darwish; I M El-Sabagh; A A El-Sanousi; M A Shalaby
Journal:  Virus Genes       Date:  2013-07-11       Impact factor: 2.332

9.  Complete genome sequence of a newcastle disease virus strain belonging to a recently identified genotype.

Authors:  François-Xavier Briand; Aurélie Henry; Paul Brown; Pascale Massin; Véronique Jestin
Journal:  Genome Announc       Date:  2013-01-24

10.  Complete genome sequence of a velogenic newcastle disease virus isolated from an apparently healthy village chicken in South India.

Authors:  Arumugam Uthrakumar; Kumanan Vijayarani; Kathaperumal Kumanan; Srinivasan Bhuvaneswari; Suresh Varma Kuchipudi; Subbiah Elankumaran
Journal:  Genome Announc       Date:  2014-06-19
View more
  3 in total

1.  Prevalence of Newcastle disease virus in feces of free-range turkeys in Enugu, Nigeria.

Authors:  Obianuju Nkiruka Okoroafor; Paul Chukwuemeka Animoke; Edmund Chidiebere Mbegbu; Chinwe Justina Aronu; John Anelom Nwanta; Boniface Anene; John Ositadimma Okoye
Journal:  Vet World       Date:  2020-07-08

2.  Vaccine Quality Is a Key Factor to Determine Thermal Stability of Commercial Newcastle Disease (ND)Vaccines.

Authors:  Nabila Osman; Danny Goovaerts; Serageldeen Sultan; Jeremy Salt; Christian Grund
Journal:  Vaccines (Basel)       Date:  2021-04-09

3.  Biological and phylogenetic characterization of a novel hemagglutination-negative avian avulavirus 6 isolated from wild waterfowl in China.

Authors:  Yanyu Chen; Zhuang Ding; Xinxin Liu; Jianjun Chen; Junjiao Li; Yidong Fei; Zhe Liu; Tobias Stoeger; Yuhai Bi; Renfu Yin
Journal:  Transbound Emerg Dis       Date:  2018-09-08       Impact factor: 5.005

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.